Mosaique: Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Primary Care Organization

Sponsor
Dr Nadia YOUNES (Other)
Overall Status
Recruiting
CT.gov ID
NCT05385666
Collaborator
(none)
1,200
5
1
33.6
240
7.1

Study Details

Study Description

Brief Summary

Frequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. The collaborative care model developed in Washington State with the introduction of a care manager is recognized. About 100 randomized controlled trials have established its effectiveness and efficiency, in terms of improving the progression of disorders (remission rate), adherence, quality of life, professional and patient satisfaction, and cost savings. However, the possibility of implementation of these validated care remains to be explored. A dozen collaborative care implementation studies exist, all conducted in the USA and not having considered all the dimensions of the indicators of penetration, acceptability/adoption, feasibility, fidelity and cost. A first implementation in France is implemented since September 2021 in the Yvelines department on four sites of different size, organization and environments: the multi-professional health centers (MSP) of Mureaux and Celle St Cloud, the Chevreuse medical house and MG in isolated practice in Versailles.

The main objective of the research project is to evaluate the first implementation in France of collaborative care for frequent psychic disorders according to the indicators of penetration, acceptability/adoption, fidelity, relevance, feasibility and cost.

Condition or Disease Intervention/Treatment Phase
  • Other: collaborative cares
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Collaborative Mental Health Care Model: an Evaluation of the Implementation of a Pilot in Four Health Homes
Actual Study Start Date :
Jul 13, 2022
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: group experimental

Other: collaborative cares
coordinate care between city medicine and specialized psychiatric care to improve the management of common mental disorders

Outcome Measures

Primary Outcome Measures

  1. to evaluate the first implementation in France of collaborative care for frequent psychic disorders [36 months]

    numbers of patients and medical caregivers who participate in collaborative care

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • healthcare professionals involved in the collaborative care system

  • patients who have been referred for collaborative care by their family physician

Exclusion Criteria:
  • patient refusal to participate in research

  • adults protected by law

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maison de Santé Pluridisciplinaire Chevreuse France 78460
2 Maison de Santé Pluridisciplinaire les Mureaux France 78130
3 Cabinet Médical Versailles Versailles France 78000
4 cabinet médical Versailles Versailles France 78000
5 Cabinet Médical Versailles Versailles France 78000

Sponsors and Collaborators

  • Dr Nadia YOUNES

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Nadia YOUNES, Investigator Coordinator, Versailles Hospital
ClinicalTrials.gov Identifier:
NCT05385666
Other Study ID Numbers:
  • P21/10_mosaïque
First Posted:
May 23, 2022
Last Update Posted:
Aug 25, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 25, 2022